OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN) [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
CORK, Ireland May 9, 2024 /PRNewswire/ -- The Vertex HFN offers an innovative approach to fracture fixation, aiming to enhance patient outcomes and streamline surgical procedures. The current approaches to hip fracture treatment often encounter hurdles such as instability, which leads to high cutout rates, limited patient mobility post-surgery, persistent pain during recovery, and nonunion complications. OrthoXel's Vertex HFN combats these clinical challenges head-on, offering a highly stable and versatile product. Vertex Solution The foundation of the Vertex system rests on three key pillars: stability, versatility, and usability. Stability - The primary aim of surgical intervention for hip fractures is stabilization, Vertex achieves this with a unique design. Two proximal interdigitating screws produce enhanced screw fixation. The radially fluted nail stem ensures rotational and overall construct stability, particularly in the intertrochanteric and metaphyseal regions of the fe
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. [Yahoo! Finance]Yahoo! Finance
- Jennifer Schneider Elected to Vertex Board of Directors [Yahoo! Finance]Yahoo! Finance
- Jennifer Schneider Elected to Vertex Board of DirectorsBusiness Wire
- Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 5/20/24 - Form 8-K
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- VRTX's page on the SEC website